AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 LifeVantageKindred BiosciencesSpero TherapeuticsNature's Sunshine ProductsMallinckrodt
SymbolNASDAQ:LFVNNASDAQ:KINNASDAQ:SPRONASDAQ:NATRNYSE:MNK
Price Information
Current Price$15.34$4.81$12.32$9.36$2.77
52 Week RangeN/ABuyBuyN/AHold
Beat the Market™ Rank
Overall Score0.91.51.61.42.0
Analysis Score0.03.33.50.04.0
Community Score2.72.62.72.33.1
Dividend Score0.00.00.00.00.0
Ownership Score1.01.01.04.01.0
Earnings & Valuation Score0.60.60.60.61.9
Analyst Ratings
Consensus RecommendationN/ABuyBuyN/AHold
Consensus Price TargetN/A$10.88$23.00N/A$7.42
% Upside from Price TargetN/A126.09% upside86.69% upsideN/A167.75% upside
Trade Information
Market Cap$216.84 million$186.23 million$266.92 million$189.83 million$235.22 million
Beta1.4411.960.693.41
Average Volume101,725265,737132,27920,5017,618,309
Sales & Book Value
Annual Revenue$225.96 million$4.26 million$18.15 million$362.21 million$3.16 billion
Price / Sales0.9744.3613.980.500.07
Cashflow$0.77 per shareN/AN/A$0.98 per share$19.79 per share
Price / Cash19.95N/AN/A9.580.14
Book Value$1.90 per share$2.10 per share$3.90 per share$6.70 per share$23.08 per share
Price / Book8.072.293.161.400.12
Profitability
Net Income$7.43 million$-61,390,000.00$-60,920,000.00$6.76 million$-996,500,000.00
EPS$0.59($1.59)($3.35)N/A$8.88
Trailing P/E Ratio19.42N/AN/A22.83N/A
Forward P/E RatioN/AN/A0.68
P/E GrowthN/AN/AN/AN/A$0.03
Net Margins5.06%-1,567.56%-654.03%2.17%-39.56%
Return on Equity (ROE)43.08%-72.77%-88.22%6.00%29.14%
Return on Assets (ROA)22.57%-56.10%-70.36%3.59%7.09%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.36%0.05%0.14%2.50%
Current Ratio1.62%5.73%4.31%2.02%1.46%
Quick Ratio0.99%5.65%4.31%1.26%1.20%
Ownership Information
Institutional Ownership Percentage47.70%66.90%52.88%77.64%78.44%
Insider Ownership Percentage6.80%12.63%18.34%16.00%3.14%
Miscellaneous
Employees220146579053,400
Shares Outstanding14.31 million39.29 million20.60 million19.47 million84.46 million
Next Earnings Date8/12/2020 (Estimated)8/6/2020 (Estimated)8/13/2020 (Estimated)8/13/2020 (Estimated)8/4/2020 (Estimated)
OptionableOptionableOptionableOptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.